Lower urinary tract symptoms - current management in older men.

Mohan Arianayagam, Ranjan Arianayagam, Prem Rashid
Author Information
  1. Mohan Arianayagam: Department of Urology, The University of Miami Miller School of Medicine, Florida, USA. m.arianayagam@yahoo.com

Abstract

BACKGROUND: Lower urinary tract symptoms are a common problem in men and the incidence of these symptoms increases with age.
OBJECTIVE: This article provides an update on the evaluation and treatment of lower urinary tract symptoms in older men. In particular, we describe current nomenclature, diagnosis, the International Prostate Symptom Score, and currently available medical and surgical treatments as well as indications for referral to a urologist.
DISCUSSION: Lower urinary tract symptoms may be divided into voiding and storage, and men may present with a combination of the two symptom groups. Voiding symptoms include weak stream, hesitancy, and incomplete emptying or straining and are usually due to enlargement of the prostate gland. Storage symptoms include frequency, urgency and nocturia and may be due to detrusor overactivity. In elderly men who present with lower urinary tract symptoms, indications for early referral to a urologist include haematuria, recurrent infections, bladder stones, urinary retention and renal impairment. In uncomplicated cases, medical therapy can be instituted in the primary care setting. Options for medical therapy include alpha blockers to relax the smooth muscle of the prostate, 5 alpha reductase inhibitors to shrink the prostate, and antimuscarinics to relax the bladder. The International Prostate Symptom Score is beneficial in assessing symptoms and response to treatment. If symptoms progress despite medical therapy or the patient is unable to tolerate medical therapy, urological referral is warranted.

MeSH Term

5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adult
Aged
Humans
Lower Urinary Tract Symptoms
Male
Middle Aged
Muscarinic Antagonists
Prostatectomy
Watchful Waiting

Chemicals

5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Muscarinic Antagonists